Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma

Published:2022-02 Issue: Volume:353 Page:109796
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Ding Xiaoyan^ORCID,Ye Nan,Qiu Minyue,Guo Hongxia,Li Junjie,Zhou Xiaoyang,Yang Maocheng,Xi Jing,Liang Yongjie,Gong Yuanxin,Li Jintao

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Natural Science Foundation Project of Chongqing

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference85 articles.

1. Imbalanced host response to SARS-CoV-2 drives development of COVID-19;Blanco-Melo;Cell,2020

2. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages;Merad;Nat. Rev. Immunol.,2020

3. Pathological findings of COVID-19 associated with acute respiratory distress syndrome;Xu;Lancet Respir. Med.,2020

4. Monocytes and macrophages in COVID-19;Knoll;Front. Immunol.,2021

5. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients;Wang;EBioMedicine,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells;Viruses;2024-08-02

2. SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients;Apoptosis;2024-07-15

3. Azvudine alleviates SARS-CoV-2-induced inflammation by targeting myeloperoxidase in NETosis;Chinese Chemical Letters;2024-07

4. Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent;BioMetals;2024-04-05

5. Compensational role between cathepsins;Biochimie;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3